Physician profile
Jamie M Monroe
NPI 1619075678
$4,389.43
in general payments reported to CMS, 2019-2025
15 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $215 · 2021: $358 · 2022: $167 · 2023: $661 · 2024: $2,299 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,090 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,089.53 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $2,340.45 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Surgical Vision, INC. | $469.67 | 2019-2025 | Catalys System, Tecnis Simplicity, Veritas Vision System |
| Ivantis, INC | $304.94 | 2020-2021 | |
| New World Medical,INC. | $277.14 | 2023-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Alcon Vision LLC | $244.70 | 2019-2023 | Hydrus Microstent, Clareon, Acrysof Iq Panoptix Uv Iol |
| Carl Zeiss Meditec USA, INC. | $187.15 | 2023 | Visumax |
| Glaukos Corporation | $140.67 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $123.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $98.14 | 2019 | |
| Beaver-Visitec International, INC. | $79.84 | 2021 | |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Amgen INC. | $21.29 | 2025 | Tepezza |
| Allergan, INC. | $18.20 | 2021 | |
| Omeros Corporation | $12.33 | 2021 | |
| Sight Sciences, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.